JLMediLabs
Develops early-diagnosis solutions that use single-molecule detection methods to identify biomarkers from microliter-scale blood samples. Focuses on sensitive, rapid, and low-cost assay approaches for early clinical detection.
Industries
health-care
health-diagnostics
medical
Nr. of Employees
small (1-50)
Products
Pan-Cancer Early Detection Test
A diagnostic test that detects multiple types of cancer early from a single blood sample using single-molecule techniques.
Pan-Cancer Early Detection Test
A diagnostic test that detects multiple types of cancer early from a single blood sample using single-molecule techniques.
Services
Early-diagnosis assay development using single-molecule detection
Development of diagnostic assays that detect biomarkers from a tiny drop of blood using single-molecule analytical techniques; aimed at sensitive, rapid, and low-cost early detection.
Early-diagnosis assay development using single-molecule detection
Development of diagnostic assays that detect biomarkers from a tiny drop of blood using single-molecule analytical techniques; aimed at sensitive, rapid, and low-cost early detection.
Expertise Areas
- Early-detection diagnostics
- Molecular assay development
- Microvolume blood testing
- Single-molecule analytical methods
Key Technologies
- Single-molecule detection
- Microvolume blood sampling
- Biomarker-based molecular assays
- Rapid assay workflows